相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
Sameer Jauhar et al.
BIOLOGICAL PSYCHIATRY (2019)
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Sameer Jauhar et al.
MOLECULAR PSYCHIATRY (2019)
Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms
Mihai Avram et al.
BRAIN (2019)
The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
Bruce J. Kinon
FRONTIERS IN PSYCHIATRY (2019)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
Theo G. M. van Erp et al.
BIOLOGICAL PSYCHIATRY (2018)
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
Rene S. Kahn et al.
LANCET PSYCHIATRY (2018)
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
Euitae Kim et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The Relationship Between Subcortical Brain Volume and Striatal Dopamine D2/3 Receptor Availability in Healthy Humans Assessed With [11C]-Raclopride and [11C]-(+)-PHNO PET
Fernando Caravaggio et al.
HUMAN BRAIN MAPPING (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia A Meta-analysis
Stefan P. Brugger et al.
JAMA PSYCHIATRY (2017)
Effect Size Estimation in Neuroimaging
Marianne C. Reddan et al.
JAMA PSYCHIATRY (2017)
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Sameer Jauhar et al.
JAMA PSYCHIATRY (2017)
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans
S. Jauhar et al.
TRANSLATIONAL PSYCHIATRY (2017)
Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?
Natalia Jaworska et al.
PLOS ONE (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Elias Mouchlianitis et al.
SCHIZOPHRENIA BULLETIN (2016)
A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment
Qiyong Gong et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity
Eric Plitman et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness
Ulysses S. Torres et al.
NEUROIMAGE-CLINICAL (2016)
Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
Tyrone D. Cannon et al.
BIOLOGICAL PSYCHIATRY (2015)
Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Meghan Elizabeth Goldstein et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients (vol 20, pg 150, 2015)
J. Frank et al.
MOLECULAR PSYCHIATRY (2015)
Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users
A. M. Morales et al.
MOLECULAR PSYCHIATRY (2015)
Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine
Il Hwan Kim et al.
NATURE NEUROSCIENCE (2015)
Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance
Ian B. Malone et al.
NEUROIMAGE (2015)
Diagnostic change 10 years after a first episode of psychosis
M. Heslin et al.
PSYCHOLOGICAL MEDICINE (2015)
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2015)
Translating the MAM model of psychosis to humans
Gemma Modinos et al.
TRENDS IN NEUROSCIENCES (2015)
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Deepak K. Sarpal et al.
JAMA PSYCHIATRY (2015)
Schizophrenia: a tale of two critical periods for prefrontal cortical development
L. D. Selemon et al.
TRANSLATIONAL PSYCHIATRY (2015)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)
Oliver D. Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Connectivity-Based Functional Analysis of Dopamine Release in the Striatum Using Diffusion-Weighted MRI and Positron Emission Tomography
Andri C. Tziortzi et al.
CEREBRAL CORTEX (2014)
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia
A. L. Guillozet-Bongaarts et al.
MOLECULAR PSYCHIATRY (2014)
Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Michael A. P. Bloomfield et al.
NEUROPSYCHOPHARMACOLOGY (2014)
THE PLACE OF DOPAMINE IN THE CORTICO-BASAL GANGLIA CIRCUIT
S. N. Haber
NEUROSCIENCE (2014)
Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects
Marco Alessandrini et al.
SCIENTIFIC REPORTS (2014)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Alice Egerton et al.
BIOLOGICAL PSYCHIATRY (2013)
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
Oliver D. Howes et al.
BRAIN (2013)
Individual Differences in Frontal Cortical Thickness Correlate with the d-Amphetamine-Induced Striatal Dopamine Response in Humans
Kevin F. Casey et al.
JOURNAL OF NEUROSCIENCE (2013)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study
Paul R. A. Stokes et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
P. Fusar-Poli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Temporal Lobe Volume Abnormalities Precede the Prodrome: A Study of Children Presenting Antecedents of Schizophrenia
Alexis E. Cullen et al.
SCHIZOPHRENIA BULLETIN (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Increased Stress-Induced Dopamine Release in Psychosis
Romina Mizrahi et al.
BIOLOGICAL PSYCHIATRY (2012)
The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder
E. Bora et al.
PSYCHOLOGICAL MEDICINE (2012)
Transition to Psychosis Associated With Prefrontal and Subcortical Dysfunction in Ultra High-Risk Individuals
Paul Allen et al.
SCHIZOPHRENIA BULLETIN (2012)
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies
A. Vita et al.
TRANSLATIONAL PSYCHIATRY (2012)
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
P. Fusar-Poli et al.
MOLECULAR PSYCHIATRY (2011)
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
O. Howes et al.
MOLECULAR PSYCHIATRY (2011)
Temporal dynamics and genetic control of transcription in the human prefrontal cortex
Carlo Colantuoni et al.
NATURE (2011)
Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis A Multimodal Imaging Study
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
Nancy C. Andreasen et al.
BIOLOGICAL PSYCHIATRY (2010)
Measurement of psychiatric treatment adherence
Martha Sajatovic et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2010)
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
Alice Egerton et al.
NEUROIMAGE (2010)
Head size, age and gender adjustment in MRI studies: a necessary nuisance?
Josephine Barnes et al.
NEUROIMAGE (2010)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Review of the operational definition for first-episode psychosis
Nicholas J. K. Breitborde et al.
EARLY INTERVENTION IN PSYCHIATRY (2009)
Cerebral morphology and dopamine D2/D3 receptor distribution in humans: A combined [18F] fallypride and voxel-based morphometry study
Neil D. Woodward et al.
NEUROIMAGE (2009)
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Yoshitaka Kumakura et al.
NEUROSCIENTIST (2009)
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals
Daqiang Sun et al.
SCHIZOPHRENIA RESEARCH (2009)
Dopaminergic Synapses in the Caudate of Subjects with Schizophrenia: Relationship to Treatment Response
Rosalinda C. Roberts et al.
SYNAPSE (2009)
Functional Connectivity of Human Striatum: A Resting State fMRI Study
A. Di Martino et al.
CEREBRAL CORTEX (2008)
Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data
Chao-Cheng Lin et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Evidence for segregated and integrative connectivity patterns in the human basal ganglia
Bogdan Draganski et al.
JOURNAL OF NEUROSCIENCE (2008)
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis
Stefan J. Borgwardt et al.
SCHIZOPHRENIA RESEARCH (2008)
A fast diffeomorphic image registration algorithm
John Ashburner
NEUROIMAGE (2007)
Defining 'response' in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs
Stefan Leucht et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy:: An [18F]Fallypride PET study
Konrad J. Werhahn et al.
EPILEPSIA (2006)
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning
C Kellendonk et al.
NEURON (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
JA Maldjian et al.
NEUROIMAGE (2003)
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
G Gründer et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum
D Martinez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Smaller frontal gray matter volume in postmortem schizophrenic brains
LD Selemon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Geometry and structural plasticity of synaptic connectivity
A Stepanyants et al.
NEURON (2002)
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
A Meyer-Lindenberg et al.
NATURE NEUROSCIENCE (2002)
Prefrontal neurons and the genetics of schizophrenia
DR Weinberger et al.
BIOLOGICAL PSYCHIATRY (2001)
Prefrontal gray matter volume reduction in first episode schizophrenia
Y Hirayasu et al.
CEREBRAL CORTEX (2001)
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
A Carlsson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
LS Kegeles et al.
BIOLOGICAL PSYCHIATRY (2000)
Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
DB Carr et al.
JOURNAL OF NEUROSCIENCE (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
A Bertolino et al.
NEUROPSYCHOPHARMACOLOGY (2000)